The global sales of cold laser therapy are estimated to be worth USD 126.9 million in 2025 and is anticipated to reach a value of USD 196.5 million by 2035. Sales are projected to rise at a CAGR of 4.5% over the forecast period between 2025 and 2035. The revenue generated by cold laser therapy in 2024 was USD 121.9 million.
The current pain management industry has seen significant development with the introduction of many therapeutic modalities including energy-based devices for treatment. Cold therapy lasers are a class of energy based devices which act as an effective tool for non-invasive treatment in management of pain and promote healing.
These are also known as Low-level lasers as they release light-emitting diodes that has been beneficial in facilitating the healing process of musculoskeletal pain, joint problems, and soft tissue damage or injury.
These devices facilitate the body's natural healing mechanisms to target the underlying causes of pain without the risks and adverse effects associated with more invasive treatments. Unlike conventional laser treatments, cold lasers do not produce heat. Hence, these devices are relatively safer and more relieving treatment for patients looking for pain relief and healing.
The cold laser therapy market has undergone rapid growth over the years, mainly because demand for non-invasive treatments has soared while incidence rates have increased amongst chronic pain cases and improving awareness about the benefits available to accrue from non-pharmacological therapies. Secondly, technological advancements related to lasers, until recent times, have been portable and user-friendly.
Global Cold Laser Therapy Industry Analysis
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 121.9 million |
| Estimated Size, 2025 | USD 126.9 million |
| Projected Size, 2035 | USD 196.5 million |
| Value-based CAGR (2025 to 2035) | 4.5% |
Ablative lasers are preferred for the treatment as they are effective and safe. Some traditional lasers have lengthy recovery and incur potential thermal damage as compared to new ablative lasers, such as excimer lasers.
In procedures using ablative lasers, an intense wavelength light is delivered on the skin to remove sun damaged skin and outer layers of aged skin.
The adoption of ablative lasers is increasing due to rising technological development in the dermatology device market, increasing aging population, increasing demand from the youth for radiant skin, and others. Therefore, ablative lasers are anticipated to increase the demand for cold laser therapy.
The demand for tattoo removal is increasing with an increase in the demand for colorful tattoos. Various colors used in tattoos require different intensities of light for their effective removal. Hence, a combination laser therapy is very effective for tattoo removal. Further, single lasers have definite limitations, such as partial clearance of the tattoo, resulting in cases of dyschromia and ink retention even after multiple sessions.
Combination laser therapies are being used for these procedures for enhanced results. Also, a device with the combination of two technologies can be used for people with different skin types. For instance, Q-switched laser with fractional laser combination products has many advantages such as faster clearing of tissues, healing blisters, and minimized number of sessions required for treatment.
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
A comparative analysis of fluctuations in compound annual growth rate (CAGR) for the cold laser therapy industry outlook between 2024 and 2025 on a six-month basis is shown below. By this examination, major variations in the performance of these markets are brought to light, and trends of revenue generation are captured hence offering stakeholders useful ideas on how to carry on with the market’s growth path in any other given year. January through June covers the first part of the year called half1 (H1), while half2 (H2) represents July to December.
The table below compares the compound annual growth rate (CAGR) for the global cold laser therapy market from 2024 to 2025 during the first half of the year. This overview highlights key changes and trends in revenue growth, offering valuable insights into market dynamics. H1 covers January to June, while H2 spans July to December. In the first half (H1) of the decade from 2024 to 2034, the business is predicted to surge at a CAGR of 5.2%, followed by a slightly lower growth rate of 4.9% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.2% (2024 to 2034) |
| H2 | 4.9% (2024 to 2034) |
| H1 | 4.5% (2025 to 2035) |
| H2 | 4.0% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 4.5% in the first half and projected to lower at 4.0% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Rising Demand for Cold Laser Therapy Driven by Benefits in Pain Management
Non-invasive pain management treatment has gain significant traction in recent past. Cold laser therapy is yet another modality that assists in pain relief and is widely accepted by healthcare professionals for certain categories of chronic pain. There is a wide adoption across care cold therapy devices in home care settings as it helps patients to receive treatment on continuously for a given duration according to patient needs.
After numerous studies, it has been concluded that cold laser therapy devices are more convenient and effective treatment option for pain disorders, musculoskeletal disorders, arthritis, wound care, and many other conditions. They have fewer side effects as compared to traditional methods, such as surgeries. Cold or low-level laser therapy is the best-known specific type of modulation therapy.
For instance, according to an article from NCBI, annually, USD 91 billion in medical expenses are spent on back pain disorders with an additional USD 50 billion indirect costs incurred due to the loss in productivity and disability benefit payments.
User-Friendly Features and Technological Progress Drive Cold Therapy Laser Sales
Continuous technological innovations in cold laser therapy devices continue to push this market. These newest devices have now made cold laser therapy far easier for use clinically and in a home setting-compact, small in size, and rather user-friendly.
To a large extent, therapy-at-home conveniences have revolutionized patient self-management possibilities independent of visits to traditional medical settings. For example, the ability to make adjustments at home and ease of operation have empowered patients, taking some burden off healthcare systems and giving reason for better outcomes.
Cold lasers have also been much improved by manufacturers in terms of precision and effectiveness, with developments in wavelength and power settings that permit more tailored treatments. These technological enhancements are improving therapeutic results not only for a wide range of conditions, including musculoskeletal pain, arthritis, and soft tissue injuries, but also made successful clinical trials in treating neurodegenerative disorders effectively.
Companies are working by reducing production costs and increasing device efficiency to make cold laser therapy accessible. Such convergence of technological innovation with ease of use makes cold laser therapy the most effective and convenient treatment modality and has further spread its reach to almost all patient demographics.
Surging Demand for Non-Invasive and Alternative Therapies Opens Market Opportunities
The growth opportunities for cold laser therapy arise from the worldwide movement towards non-invasive treatments and alternative therapies. Increasing awareness about long-term medication side effects, especially in pain management and chronic ailments, bolsters demand for drug-free solutions. Thus, cold laser therapy has grown in popularity because it fosters healing and pain with no use of pharmaceuticals and is a natural and non-addictive alternative.
Opioid crisis remains as a concern across many countries. This crisis has led to many discussions on the continuous use of pain medication and future negative impact on the patient health. This trend remains prominent in those countries where the opioid crisis has raised concern about the safety and long-term effects of pain medications. The health care systems and the Ministry of Healthcare across all countries are increasingly focusing on a cost-effective solution that can be a suitable alternative in treating chronic pain management.
This makes the opportunities for market penetration very compelling due to the Cold Laser Therapy options that can handle these needs, reducing dependence on very expensive surgical procedures and pharmaceuticals. Indeed, the market is expected to continue growing as more and more patients, along with general practitioners, start looking for alternative, non-invasive therapies for pain management and healing processes.
High Upfront Costs and Limited Insurance Coverage Pose Market Challenges
High initial investment has been a major restraint factor for the cold laser therapy market, as these devices, though very effective for treatment, come at high prices, which keeps many small clinics and individual practitioners who want to be participants in the healthcare sector from investing in cold laser therapy technology. This is further exacerbated by the costs related to the lack of maintenance, training, and calibration of the devices-things that may further discourage prospective buyers, especially from a region with a meager health budget.
Another challenge to the wider growth of this market is related to the lack of general insurance coverage for cold laser therapy. Most insurance companies, particularly in USA and European markets, have not included cold laser treatments within the ambit of their service reimbursement. This makes certain patients bear a substantial part of the costs out-of-pocket, preventing access to the treatment in low-income groups.
This also presents a problem in terms of wide-scale acceptance, as many people may not be able or willing to pay for therapy without reimbursement options. Market penetration is likely to get better once insurance providers become more open to covering such non-invasive treatments as cold laser therapy. Till then, though, it remains a very real financial barrier.
The global cold laser therapy industry recorded a CAGR of 4.0% during the historical period between 2020 and 2024. The growth of the cold laser therapy diagnostics industry was positive as it reached a value of USD 121.9 million in 2024 from USD 104.0 million in 2020.
Cold laser therapy was initially used as an adjunct treatment in physical therapy and rehabilitation for the reduction of inflammation and to speed up the process of healing. The rate of diffusion, however, had been very slow due to high equipment costs and limited clinical evidence; as the studies supporting its efficacy grew, demand for cold laser devices increased gradually.
In the present scenario, cold laser therapy has gained phenomenal momentum in the market, with North America and Europe holding significant shares. Besides the ever-growing aging population, more people these days seek alternatives for the treatment of chronic pain that is not invasive, and thus, this field is also extending. Medical practitioners involved in orthopedics, physical therapy, and chiropractic care have aligned cold laser therapy in their therapeutic procedures for better patient outcomes and have extended the reach of this market as well.
The cold laser therapy market is thus expected to witness considerable growth in the forecast period. The period forecasts an increase in awareness of the effectiveness of non-pharmacological treatments and a wide diffusion of cold laser devices within medical facilities, sports clinics, and even home-use settings.
Market expansion is also expected to be seen in emerging economies as more advanced healthcare technologies are adopted. The technological development will further enhance the market, since as laser devices are made cheaper and their efficiency improved, the area of their application will be expanded for many medical conditions.
Tier 1 players in this market holds 55.2%. In the tier 1 are companies with a significant global presence, such as Apira Science Inc, B-Cure laser Australia, Erchonia Corporation, DJO Global, Inc., BTL. These companies have a diverse product portfolio, including cutting-edge cold laser devices and strong distribution networks across multiple regions. They are industry leaders, recognized for their high-quality devices and extensive research and development.
In the tier 2, companies like BioLight Technologies LLC, THOR Photomedicine Ltd, Irradia are prominent players that occupies around 18.1% market share with a solid presence in specific regional markets. These firms are often innovators, focusing on specialized solutions and catering to niche segments such as pain management and dermatological treatments.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The section below covers the cold laser therapy industry analysis for the sales for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East & Africa is provided. The United States is anticipated to remain at the forefront in North America, with a CAGR of 3.8% through 2035. In South Asia & Pacific, India is projected to witness the highest CAGR in the market of 6.1% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 3.8% |
| Germany | 4.4% |
| UK | 3.4% |
| China | 6.1% |
| India | 6.1% |
| Japan | 6.6% |
The United States dominates the global market with a maximum share in 2024. The market exhibits a CAGR of 3.8% over the forecast period 2025 to 2035.
United States challenge on opioid crisis has brought new dimensions into healthcare practices, placing added scrutiny on pharmaceutical interventions towards chronic pain. But beyond their addictive nature, pain medications have enough side effects and long-term use issues to warrant legitimate alternative which is non-addictive and with minimal side effects.
Cold laser therapy, at this point, presents a very interesting alternative. The cold laser is extremely effective for such conditions as arthritis, sports injuries, tendinitis, and back pain without the risks associated with pharmaceuticals. This makes it especially popular among patients as a non-invasive treatment when they seek to pursue a course of pain management that does not include drugs.
Such has introduced a new frontier in pain management, with new attitudes setting a course to turn the US Health System more preventive and non-pharmaceutical. This becomes quite an especially favorable context that cold laser therapy finds fertile soil on. Under these circumstances, cold laser therapy is in a position to play an important role in managing a number of chronic pains with minimum dependence on opioids and other pharmaceuticals, while the market for non-invasive pain therapies continues to expand.
In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 4.4%.
German leadership in medical innovation stretches to cold laser therapy. More precisely, with its long-standing tradition of precision engineering, Germany is a home for a number of manufacturing companies with high-quality and state-of-the-art medical devices as their focal point. More specifically, firms from this country are competent enough to incorporate the latest laser developments into cold laser treatment devices.
This includes the development of laser wavelength, power output, and precision of treatment with the view of optimizing therapeutic effects for a variety of conditions including musculoskeletal pain, joint disorders, and soft tissue injuries.
A key driving factor for the growth of cold laser therapy in Germany is the increasing demand within the healthcare system for treatment without invasion. Considering the robustness of the healthcare infrastructure, the belief in advanced technologies by German medical professionals continues to adopt the cold laser therapy particularly for rehabilitation and physiotherapy purposes.
New, very effective, and inexpensive portable devices have greatly enhanced the accessibility of this therapy, allowing it to be employed not only in the hospital setting but also in outpatient clinics and even home care.
Preciseness and efficiency are the characteristics of German medical devices, and this corresponds with the growing interest in non-invasive treatments around the world. This trend, combined with an already established medical device industry in Germany, is very likely to further spur the market for cold laser therapy in the country as the demand for more advanced, efficient, and user-friendly devices rises.
India occupies a leading value share in South Asia & Pacific market in 2024 and is expected to grow with a CAGR of 6.1% during the forecasted period.
Most specifically, India is experiencing significant demand within its healthcare market for non-invasive, affordable pain management treatments, with chronic pain and musculoskeletal disorders being on the rise. The country also has a growing middle class increasingly interested in alternatives to invasive procedures; therefore, cold laser therapy has gained acceptance as an effective option that is drug-free.
Adverse side effects of medicines involved in conventional treatments or high costs of surgical interventions have led many patients towards the treatment of cold laser therapy. The modality of treatment being non-invasive, safe, and inexpensive, and the easy integration of therapy into one's daily routine means lesser number of visits one has to make to clinics.
Also, the transition of India toward preventive health care is one factor in cold laser therapy's growth. With growing awareness among people for alternative therapies, especially among the younger, health-conscious population, cold laser therapy is placed as a proactive treatment to avoid bigger medical conditions and surgeries. This is the reason why demand is on the rise not only in pain management centers but also in wellness and fitness clinics, where people seek non-pharmacological ways of managing pain and enhancing recovery.
The section contains information about the leading segments in the industry. Based on product type, continuous laser devices systems are expected to account 54.6% of the global share in 2025.
| Product Type | Value Share (2025) |
|---|---|
| Continuous Laser Devices | 54.6% |
By product type, continuous laser devices will dominate the cold laser therapy market with a share of 54.6% in 2025. Continuous type lasers have emerged as the dominant product category within the cold laser treatment market due to their capabilities of providing steady and concentrated therapy for extended durations. These types of devices ensure that the light deeply penetrates tissues; such tissue penetration is necessary to effectively trigger cellular repair processes and reduce inflammation.
Besides, continuous lasers are preferred in the clinical environment for their precision in dosage control, which is just what is desired for therapeutic applications that require consistency and predictability of results. The control and reliability at this level make the continuous laser devices quite attractive, especially for medical professionals and patients after effective pain management for the long term.
| By End User | Value Share (2025) |
|---|---|
| Specialty Clinics | 43.1% |
Specialty clinics will account for 43.1% of the end user segment in 2025, and exhibit the highest CAGR in the forecast period.
Specialty clinics, such as pain management centers, physiotherapy practices, and sports rehabilitation centers, are the largest end-user segment for cold laser therapy. These are specialty clinics that focus their operations on the treatment of chronic pain, injury recovery, and musculoskeletal disorders-all indications where cold laser therapy is particularly effective.
The non-invasive nature of cold laser therapy remains one of the leading benefits for clinics and is considerably more pleasing than the idea of avoiding surgery or taking lengthy medication. Other advantages, as mentioned earlier in the report, in using cold lasers are also handled appropriately with better knowledge in these specialist clinics, enhanced to provide the best results to the patient, hence allowing the segment to expand within the market further.
The competitive landscape of the cold laser therapy market is characterized by the presence of several key players, including both established medical device manufacturers and emerging companies focused on innovative technologies. Major players such as Erchonia Corporation, Theralase Inc., and Apira Science Inc. are leading the market with advanced laser devices, while smaller companies are increasingly entering the space, offering specialized products.
Competitive strategies primarily revolve around technological innovation, product differentiation, and expanding applications, with a growing emphasis on affordability and accessibility.
Recent Industry Developments in Cold Laser Therapy Market
In terms of product type, the industry is divided into continuous laser devices, pulse laser devices, and combination laser devices.
In terms of technology, the industry is divided into single wavelength cold laser therapy devices and multiple wavelength cold laser therapy devices
In terms of application, the industry is divided into pain management, arthritis, wound healing, nerve regeneration, dermatology, musculoskeletal, and others
In terms of end user, the industry is segregated into hospitals, specialty clinics, ambulatory surgical centers and homecare settings.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe, and Middle East and Africa (MEA) have been covered in the report.
The global cold laser therapy industry is projected to witness CAGR of 4.5% between 2025 and 2035.
The global cold laser therapy industry stood at USD 121.9 million in 2024.
The global cold laser therapy industry is anticipated to reach USD 196.5 million by 2035 end.
China is expected to show a CAGR of 6.1% in the assessment period.
The key players operating in the global cold laser therapy industry include Apira Science Inc, BioLight Technologies LLC, B-Cure laser Australia, Erchonia Corporation, Theralase Inc., THOR Photomedicine Ltd, DJO Global, Inc., BTL, Spectro Analytic Irradia AB, and Photomedex
| Market Value for 2023 | USD 5,213.0 million |
|---|---|
| Market Value for 2033 | USD 9,820.3 million |
| Market Forecast CAGR for 2023 to 2033 | 6.5% |
| Market CAGR (2023 to 2033) | 7.0% |
|---|---|
| Market Size (2023) | USD 156.5 million |
| Market Size (2033) | USD 308.6 million |
| Market Value (2023) | USD 1,767.8 billion |
|---|---|
| Market Anticipated Value (2033) | USD 3,487.8 billion |
| Market CAGR (2023 to 2033) | 7.0% |
Explore Therapeutic Device Insights
View Reports
Cold Laser Therapy Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
